CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
-
date post
21-Dec-2015 -
Category
Documents
-
view
214 -
download
0
Transcript of CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
![Page 1: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/1.jpg)
![Page 2: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/2.jpg)
CVD Risk Factor Reduction
Kelly Moore, MD, FAAPIHS Division of Diabetes Treatment &
Prevention
![Page 3: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/3.jpg)
Overview• Standards of Care
• Current Quality of CVD Care
• Purpose of Competitive Grant Program
• Case Management Tools
![Page 4: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/4.jpg)
Standards of Care IHS Standards of Care for Patients
with Type 2 Diabetes (August 2003) Includes recommendation for treatment of CVD
Risk Factors• Target BP < 130/80 mm Hg• LDL < 100 mg/dl• Antiplatelet Therapy• Tobacco cessation• Self-Management Education
![Page 5: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/5.jpg)
Standards of Care IHS Best Practice Models
Cardiovascular Disease and Diabetes• Suggested practice models, levels of service and
components of care• Additional information on standards, target for
treatment
![Page 6: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/6.jpg)
Impact of CVD
Number 1 cause of death in AI/ANs People with diabetes are 3-4 times
more likely to develop CVD Prevalence, mortality increasing Level of awareness of the link between
diabetes and CVD needs to be raised
![Page 7: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/7.jpg)
Quality of Care - CVD Risk Reduction in AI/ANs with Diabetes
Evidence/DataIHS Diabetes Care and Outcomes Audit
![Page 8: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/8.jpg)
Diabetes Care & Outcomes Diabetes Care & Outcomes AuditAudit
7
7.5
8
8.5
9
9.5
10
'94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04
Source: IHS National DiabetesProgram Statistics 1994-2004
A1C,
%
Mean A1C, 1994-2004
*p<0.0001 comparing mean HbA1 levels in FY94 and FY04
![Page 9: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/9.jpg)
Diabetes Care & Outcomes Diabetes Care & Outcomes AuditAudit
7
7.5
8
8.5
9
9.5
10
'94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04
<55
55-64
65+
Source: IHS National DiabetesProgram Statistics 1994-2004
A1C,
%
Glycemic control, 1994-2004
*p<0.0001 comparing mean HbA1 levels in FY94 and FY04
![Page 10: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/10.jpg)
0
20
40
60
80
'97 '98 '99 '00 '01 '02 '03 '04
LDL Tested
Diabetes Care & Outcomes Diabetes Care & Outcomes AuditAudit
Source: IHS National DiabetesProgram Statistics 1994-2004
Performance Measure: Dyslipidemia Assessment1998-2004
Per
cent
![Page 11: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/11.jpg)
80
100
120
140
160
180
200
220
240
260
280
'94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04
Mean Chol
Mean TGs
Mean LDL
Diabetes Care & Outcomes Diabetes Care & Outcomes AuditAudit
Source: IHS National DiabetesProgram Statistics 1994-2004
Mean Lipid Values1994-2004
mg
/dl
![Page 12: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/12.jpg)
0
20
40
60
80
100
'94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04
BP <140/<90
Diabetes Care & Outcomes Diabetes Care & Outcomes AuditAudit
Source: IHS National DiabetesProgram Statistics 1994-2004
Blood Pressure Control1994-2004
Per
cent
![Page 13: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/13.jpg)
0
20
40
60
80
100
'94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04
BP <130/<80
Diabetes Care & Outcomes Diabetes Care & Outcomes AuditAudit
Source: IHS National DiabetesProgram Statistics 1994-2004
Blood Pressure Control1994-2004
Per
cent
![Page 14: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/14.jpg)
10
20
30
40
'98 '99 '00 '01 '02 '03 '04
Tobacco Use
Use Undetermined
Diabetes Care & Outcomes Diabetes Care & Outcomes AuditAudit
Source: IHS National DiabetesProgram Statistics 1994-2004
Tobacco Use 1998-2004
Per
cent
![Page 15: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/15.jpg)
0
20
40
60
80
100
'99 '00 '01 '02 '03 '04
On ASA
Diabetes Care & Outcomes Diabetes Care & Outcomes AuditAudit
Source: IHS National DiabetesProgram Statistics 1994-2004
Aspirin Therapy1999-2004
Per
cent
![Page 16: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/16.jpg)
0
20
40
60
80
100
'94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04
Self Manag't Educ
Diabetes Care & Outcomes Diabetes Care & Outcomes AuditAudit
Source: IHS National DiabetesProgram Statistics 1994-2004
Self Management Education1999-2004
Per
cent
![Page 17: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/17.jpg)
Diabetes Care & Outcomes Diabetes Care & Outcomes AuditAudit
Source: IHS National DiabetesProgram Statistics 1994-2004
Self Management Education1994-2004
Per
cent
20
40
60
80
'94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04
Diet Instr Exercise Other DM Educ
![Page 18: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/18.jpg)
CGP CVD Risk Reduction Demonstration Project
Purpose: To implement an intensive, clinic based case
management approach to CVD Risk Reduction in individuals with Diabetes
Demonstration Project - Intensive treatment to target goals based on standards of care
Eligibility for Intensive Activities Adults with Diagnosis of Diabetes With or without CVD Exclusions (pregnant, ESRD, alcohol/substance abuse)
![Page 19: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/19.jpg)
Core Elements: Case Management
Case Management Team
Case Management Strategy Individual case management Disease management Self-management education
Tools for Case Management Diabetes Registries Diabetes Management System/RPMS Integrated Case Management System
![Page 20: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/20.jpg)
Role of Data Systems in Improving Patient Care in
Diabetes Individual Patient Level
Track one or many patients Identify specific clinical information Reminders/prompts
Population Level Calculate rates Measure performance Improve systems
![Page 21: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/21.jpg)
Diabetes Management System
DMS Package in RPMS Several applications to view
individual patient data Screen access for direct data
entry “Integrated” e-mail, recall
![Page 22: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/22.jpg)
Diabetes Management System
Diabetes Registry Data Items Maintained in the Diabetes
Registry - Patient Status - Type of Diabetes - Complications - Register Provider and Case Manager - Facility Where Patient is Routinely
Followed - Family Members - Last and Next Case Review Dates - Recall Date (Optional)
![Page 23: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/23.jpg)
Diabetes Management System
Diabetes Registry Lists Patient Status
Active, Inactive, Transient, Lost to Followup, Unreviewed, Deceased, Non-IHS Care
Diagnosis Type 1, Type 2, Gestational, IGT
Complications CVA (Stroke), Myocardial Infarction, End Stage
Renal Disease, Hypertension, Retinopathy, Laser Treatment for Retinopathy, High Risk Foot, Minor Amputation, Major Amputation(s)
![Page 24: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/24.jpg)
Diabetes Management System
Diabetes Patient Care Summary Used by provider to manage/update care
during clinical encounter “Electronic” flowsheet – to do lists for
recommended care A part of Adult Health Summary
Electronic Audits using DMS/RPMS Nationally defined audit elements
Integrated Case Management Package Documentation of care plans, in development
![Page 25: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/25.jpg)
![Page 26: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/26.jpg)
![Page 27: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/27.jpg)
Capacity to Use DMS in CGP RPMS Survey – CGP CVD Grant Programs
Question Percent
Sites using RPMS 92
Sites with DMS Package installed 90
Sites using DMS 76
Sites conducting electronic audits 45
![Page 28: CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.](https://reader030.fdocuments.us/reader030/viewer/2022032704/56649d695503460f94a47627/html5/thumbnails/28.jpg)
Next Steps
Treatment of CVD Risk Factors As a part of intensive case management strategy Grantee Panel discussion/questions
Core Elements: Case Management Draft protocol/required elements for discussion
Explore DMS as an option May need to schedule additional training Use of paper tracking until everyone using Need to consider those not on RPMS